APA

Ophorst O. J. A. E., Kostense S., Goudsmit J., De Swart R. L., Verhaagh S., Zakhartchouk A., Van Meijer M., Sprangers M., Van Amerongen G., Yüksel S., Osterhaus A. D. M. E. & Havenga M. J. E. (20041110). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. : Vaccine.

Chicago

Ophorst Olga J A E, Kostense Stefan, Goudsmit Jaap, De Swart Rik L, Verhaagh Sandra, Zakhartchouk Alexander, Van Meijer Marja, Sprangers Mieke, Van Amerongen Geert, Yüksel Selma, Osterhaus Albert D M E and Havenga Menzo J E. 20041110. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. : Vaccine.

Harvard

Ophorst O. J. A. E., Kostense S., Goudsmit J., De Swart R. L., Verhaagh S., Zakhartchouk A., Van Meijer M., Sprangers M., Van Amerongen G., Yüksel S., Osterhaus A. D. M. E. and Havenga M. J. E. (20041110). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. : Vaccine.

MLA

Ophorst Olga J A E, Kostense Stefan, Goudsmit Jaap, De Swart Rik L, Verhaagh Sandra, Zakhartchouk Alexander, Van Meijer Marja, Sprangers Mieke, Van Amerongen Geert, Yüksel Selma, Osterhaus Albert D M E and Havenga Menzo J E. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. : Vaccine. 20041110.